Stocks
Akers Biosciences IncAKER
HealthcareDiagnostics
Akers Biosciences develops and markets rapid diagnostic tests and related products, with a focus on respiratory and allergy testing. The company generates revenue through its proprietary test platforms and has faced ongoing challenges in scaling commercial adoption. Investors track AKER for its potential in the point-of-care diagnostics market and its ability to secure distribution partnerships.
Congressional Interest in Akers Biosciences Inc (AKER)
1 member of Congress has disclosed 1 trade in Akers Biosciences Inc (AKER), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading AKER?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-10-05 | KENNY MARCHANT | buy | $1K-$15K |